Bristol‑Myers Squibb Announces Dividend

NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Bristol-Myers Squibb Company (NYSE: BMY) today declared a quarterly dividend of forty one cents ($0.41) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on November 1, 2019, to stockholders of record at the close of business on October 4, 2019.

The directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable December 2, 2019 to stockholders of record at the close of business on November 5, 2019.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190911005721/en/

Media:
Carrie Fernandez, 609-252-5222, [email protected]

Investors:
Tim Power, 609-252-7509, [email protected]

Source: Bristol-Myers Squibb Company

You May Also Be Interested In

• Real and RE/MAX Holdings Announce Real’s Receipt of Court Approval of Proposed Arrangement in Connection with Proposed Combination
• TriCo Bancshares Announces Quarterly Cash Dividend
• Imperium AI Founder and Filmmaker Shazir Mucklai Weighs Tom Holland and Zendaya or Kylie Jenner and Timothée Chalamet for Bollywood-Inspired Superhero Franchise